Actively Recruiting
Dragon Boat Race Versus Family Unsupervised Training to Improve the Physical Function and Quality of Life in Breast Cancer Patients
Led by First Affiliated Hospital of Zhejiang University · Updated on 2025-09-09
72
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Investigators plans to conduct a randomized, open, single center clinical study of Dragon Boat Race versus family unsupervised training to improve the physical function and quality of life in breast cancer patients to compare the effects of organized and supervised short-term dragon boat training versus unsupervised home training on body composition, physical function, and quality of life in women after breast cancer surgery. Participants will be assigned to the following intervention protocols at a 1:1 ratio:Dragon Boat Training Group (DB): Conduct 12-week dragon boat training under the guidance of professional coaches.Home-based Unsupervised Training Group (HG): Perform exercises at home independently according to instructional videos for 12 weeks.The primary outcomes are to analyze differences in body composition, physical function, and quality of life.The secondary exploratory outcomes include stratified factors such as menopausal status and surgical methods
CONDITIONS
Official Title
Dragon Boat Race Versus Family Unsupervised Training to Improve the Physical Function and Quality of Life in Breast Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female patients aged 18 to 75 years
- ECOG performance status of 0 or 1
- Body mass index (BMI) between 18.0 and 30.0
- No prior experience with dragon boat or kayaking
- Histologically or pathologically confirmed invasive breast cancer
- Adequate organ function based on blood tests, liver function, kidney function, heart function, and ECG
- Use of effective contraception for premenopausal or non-sterilized women during and 6 months after treatment
- Voluntary participation, informed consent signed, good compliance, and willingness to follow up
You will not qualify if you...
- Stage IV breast cancer
- Inflammatory breast cancer
- Previous anti-tumor or radiotherapy for malignant tumors (except cured carcinoma in situ or certain skin cancers)
- Participation in other clinical trials with anti-tumor therapies
- Regular moderate to vigorous exercise at least twice weekly
- Severe heart disease or discomfort, including heart failure, serious arrhythmias, angina needing medication, significant valvular disease, or ECG showing myocardial infarction
- Poorly controlled high blood pressure after treatment
- Active infections needing treatment, immunodeficiency, or organ transplant history
- Active chronic hepatitis B or C (except stable or cured cases)
- Other chronic diseases such as hypertension, diabetes, coronary heart disease, or COPD
- Unable to tolerate moderate to vigorous exercise
- Pregnant or lactating women, or women unwilling to use contraception during and after the trial
- Severe other diseases or conditions making participation unsuitable based on investigator judgment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The First Affiliated Hospital of Zhejiang University
Hangzhou, China
Actively Recruiting
Research Team
Z
Zhijun Dai Professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here